Pledpharma AB
Records under this name other than patents Pledpharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Pledpharma AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,688,087 | Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,187,509 | Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment Formerly held In force · High confidence | In force | High confidence | |
| US 9,597,334 | Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment Formerly held In force · High confidence | In force | High confidence | |
| US 10,111,893 | Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment Formerly held In force · High confidence | In force | High confidence | |
| US 11,260,060 | Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,633,174 | Compounds for use in the treatment of cancer Formerly held Lapsed on the fee record Ended Jan 21, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 21, 2026 | From the USPTO record |
| US 8,377,969 | Compounds for use in the treatment of cancer Formerly held Lapsed on the fee record Ended Feb 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 19, 2025 | From the USPTO record |